Erwin Lamping

2.7k total citations · 1 hit paper
44 papers, 2.1k citations indexed

About

Erwin Lamping is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Erwin Lamping has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 21 papers in Epidemiology and 18 papers in Oncology. Recurrent topics in Erwin Lamping's work include Antifungal resistance and susceptibility (20 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (16 papers). Erwin Lamping is often cited by papers focused on Antifungal resistance and susceptibility (20 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (16 papers). Erwin Lamping collaborates with scholars based in New Zealand, Japan and Thailand. Erwin Lamping's co-authors include Richard D. Cannon, Ann R. Holmes, Brian C. Monk, Masakazu Niimi, Kyoko Niimi, Koichi Tanabe, Mikhail V. Keniya, André Goffeau, Philippe V. Baret and Yoshimasa Uehara and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Clinical Microbiology Reviews.

In The Last Decade

Erwin Lamping

43 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efflux-Mediated Antifungal Drug Resistance

2009 456 citations Richard D. Cannon, Erwin Lamping et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erwin Lamping New Zealand	20	1.2k	875	745	323	282	44	2.1k
Mikhail V. Keniya New Zealand	16	959 0.8×	597 0.7×	479 0.6×	222 0.7×	211 0.7×	30	1.7k
Patrick Marichal Belgium	27	1.5k 1.2×	1.1k 1.3×	699 0.9×	211 0.7×	398 1.4×	38	2.6k
Masakazu Niimi Japan	31	2.3k 1.9×	1.7k 1.9×	1.1k 1.5×	488 1.5×	447 1.6×	88	3.4k
Sudagar S. Gurcha United Kingdom	32	1.2k 1.0×	1.0k 1.2×	1.6k 2.1×	101 0.3×	205 0.7×	61	3.1k
Elisabetta Balzi Belgium	21	785 0.7×	553 0.6×	2.1k 2.8×	891 2.8×	505 1.8×	29	3.3k
Lan Yan China	25	846 0.7×	496 0.6×	654 0.9×	94 0.3×	433 1.5×	82	1.9k
L A Collins United States	13	971 0.8×	685 0.8×	880 1.2×	103 0.3×	179 0.6×	15	2.3k
Amy Flattery United States	22	1.8k 1.5×	1.2k 1.4×	518 0.7×	136 0.4×	467 1.7×	37	2.5k
Françoise Ischer Switzerland	22	3.5k 2.9×	2.6k 3.0×	1.1k 1.5×	457 1.4×	581 2.1×	25	4.5k
Patrick Vandeputte France	20	1.0k 0.9×	764 0.9×	487 0.7×	64 0.2×	405 1.4×	39	1.8k

Countries citing papers authored by Erwin Lamping

Since Specialization

Citations

This map shows the geographic impact of Erwin Lamping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Lamping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Lamping more than expected).

Fields of papers citing papers by Erwin Lamping

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Lamping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Lamping. The network helps show where Erwin Lamping may publish in the future.

Co-authorship network of co-authors of Erwin Lamping

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin Lamping. A scholar is included among the top collaborators of Erwin Lamping based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin Lamping. Erwin Lamping is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lamping, Erwin, et al.. (2025). Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus. Journal of Antimicrobial Chemotherapy. 80(11). 3065–3078. 1 indexed citations

Zhao, Ming, Erwin Lamping, Kyoko Niimi, Masakazu Niimi, & Richard D. Cannon. (2025). Functional analysis of Candida albicans Cdr1 through homologous and heterologous expression studies. FEMS Yeast Research. 25.

Puttarak, Panupong, et al.. (2025). Yeast-derived glycolipids disrupt Candida biofilm and inhibit expression of genes in cell adhesion. Scientific Reports. 15(1). 20405–20405. 1 indexed citations

Lamping, Erwin, et al.. (2021). Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1. mSphere. 6(1). 6 indexed citations

Lamping, Erwin, et al.. (2021). PDR Transporter ABC1 Is Involved in the Innate Azole Resistance of the Human Fungal Pathogen Fusarium keratoplasticum. Frontiers in Microbiology. 12. 673206–673206. 10 indexed citations

Lamping, Erwin, Jingyi Zhu, Masakazu Niimi, & Richard D. Cannon. (2017). Role of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family. Genetics. 205(4). 1619–1639. 10 indexed citations

Santos, Alcindo A. Dos, et al.. (2016). Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole. Antimicrobial Agents and Chemotherapy. 61(1). 19 indexed citations

Iwatani, Shun, Takahiro Oura, Nongnuch Vanittanakom, et al.. (2016). Identification and functional characterization ofPenicillium marneffeipleiotropic drug resistance transportersABC1andABC2. Medical Mycology. 54(5). 478–491. 9 indexed citations

Iwatani, Shun, Takahiro Oura, Yasuyuki Tomita, et al.. (2016). Identification and characterization ofCandida utilismultidrug efflux transporterCuCdr1p. FEMS Yeast Research. 16(4). fow042–fow042. 13 indexed citations

10.

Niimi, Kyoko, David Harding, Ann R. Holmes, et al.. (2012). Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a d‐octapeptide derivative inhibitor. Molecular Microbiology. 85(4). 747–767. 38 indexed citations

11.

Tanabe, Koichi, Erwin Lamping, Minoru Nagi, et al.. (2011). Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function. Molecular Microbiology. 82(2). 416–433. 18 indexed citations

12.

Lamping, Erwin & Richard D. Cannon. (2010). Use of a Yeast-Based Membrane Protein Expression Technology to Overexpress Drug Resistance Efflux Pumps. Methods in molecular biology. 666. 219–250. 4 indexed citations

13.

Cannon, Richard D., Erwin Lamping, Ann R. Holmes, et al.. (2009). Efflux-Mediated Antifungal Drug Resistance. Clinical Microbiology Reviews. 22(2). 291–321. 456 indexed citations breakdown →

14.

Tanabe, Koichi, Erwin Lamping, Kyoko Adachi, et al.. (2007). Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium. Biochemical and Biophysical Research Communications. 364(4). 990–995. 59 indexed citations

15.

Niimi, Kyoko, Katsuyuki Maki, Fumiaki Ikeda, et al.. (2006). Overexpression ofCandida albicans CDR1,CDR2, orMDR1Does Not Produce Significant Changes in Echinocandin Susceptibility. Antimicrobial Agents and Chemotherapy. 50(4). 1148–1155. 105 indexed citations

16.

Holmes, Ann R., Sarah Tsao, Erwin Lamping, et al.. (2006). Heterozygosity and functional allelic variation in theCandida albicansefflux pump genesCDR1andCDR2. Molecular Microbiology. 62(1). 170–186. 52 indexed citations

17.

Niimi, Masakazu, Shun‐ichi Wada, Koichi Tanabe, et al.. (2005). Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae.. PubMed. 58(1). 1–7. 18 indexed citations

18.

Niimi, Masakazu, Koichi Tanabe, Shun‐ichi Wada, et al.. (2005). ABC Transporters of Pathogenic Fungi: Recent Advances in Functional Analyses. Nippon Ishinkin Gakkai Zasshi. 46(4). 249–260. 9 indexed citations

19.

Wada, Shun‐ichi, Koichi Tanabe, Akiko Yamazaki, et al.. (2004). Phosphorylation of Candida glabrata ATP-binding Cassette Transporter Cdr1p Regulates Drug Efflux Activity and ATPase Stability. Journal of Biological Chemistry. 280(1). 94–103. 29 indexed citations

20.

Vincze, Éva, et al.. (1994). Repression of the L-asparaginase gene during nodule development in Lupinus angustifolius. Plant Molecular Biology. 26(1). 303–311. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact